Abstract
This report analyzes the worldwide markets for Osteoporosis Therapeutics in
Millions of US$. The specific product segments analyzed are Bisphosphonates,
ERT Drugs, SERMs, and Calcitonins. The report provides separate comprehensive
analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are
provided for each region and product segment for the period of 2000 through
2015. The report profiles 52 companies including many key and niche players
worldwide such as Eli Lilly and Company, F.Hoffmann-La Roche Ltd, Merck & Co.,
Inc., Novartis AG, Novo Nordisk, Organon, Procter & Gamble Pharmaceuticals,
Inc., Sanofi-Aventis SA, Servier SA, Solvay Pharmaceuticals, Inc., Unigene
Laboratories, Inc., and Wyeth. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly extracted from URL
research and reported select online sources.
| 
View Cart
